Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 9th Neuropsychiatric Drug Development Summit.

Pharma Powerhouses Driving Psychiatric Innovation
Biotech Trailblazers Transforming Mental Health Therapeutics
Investor, Regulatory & Strategic Voices Shaping Psychiatric R&D
Academic Titans & Clinical Thought Leaders
CRO Innovators Accelerating CNS Research

Pharma Powerhouses Driving Psychiatric Innovation

Derek Buhl

Derek Buhl

Scientific Director
AbbVie

Chris Ocampo

Head of Psychiatry, Neuroscience Clinical Development
Abbvie
Lawrence Park

Lawrence Park

Executive Medical Director, Clinical Development
AbbVie
Samir Koirala

Samir Koirala

Vice President & Head of Neurobiology Research
Alkermes
James Cronican

James Cronican

Head Vice President, Experimental Medicine Neuroscience & Mental Health
Boehringer Ingelheim
Pranab Kalita

Pranab Kalita

Head of Clinical Development, Experimental Medicine, Neuroscience & Mental Health
Boehringer Ingelheim
Gerard Zitnik

Gerard Zitnik

Director, Worldwide Medical Neuroscience
Bristol Myers Squibb
Johan Luthman

Johan Luthman

Head Executive VP, Research & Development
Lundbeck
Veronika Logonvinsky

Veronika Logonvinsky

VP Clinical Devlopment
Lundbeck
Matt Harlin

Matthew Harlin

Senior Director, Discovery Research, Early Phase & Translational Medicine
Otsuka Pharmaceutical Companies (U.S.)

Biotech Trailblazers Transforming Mental Health Therapeutics

Steve Levine

Chief Patient Officer
COMPASS Pathways
Guy Goodwin

Guy Goodwin

Chief Medical Officer
Compass Pathways

Zoe Hughes

Vice President Biology & Translational Medicine
Gilgamesh Pharmaceuticals
Amir Inamda

Amir Inamdar

Chief Medical Officer
Helus Pharma

Andrew Miller

Founder
Karuna Therapeutics
Jens Wendland

Jens Wendland

Chief Medical Officer
Kynexis Therapeutics

Jenny Barnett

Co-Founder & Chief Executive Officer
Monument Therapeutics
Nick Brandon

Nick Brandon

Chief Scientific Officer
Neumora
Mikhail Kalinichev

Mikhail Kalinichev

Head of Translational Science
Neurosterix
Magali Haas

Magali Haas

Chief Medical Officer
Psilera
Michael Chen

Michael Chen

Chief Scientific Officer
Seaport Therapeutics
Aaron Koeing

Aaron Koenig

Chief Medical Officer
Syndeio Biosciences

Sam Banister

Co-Founder & Scientific Chief & Officer
XYLO Therapeutics

Investor, Regulatory & Strategic Voices Shaping Psychiatric R&D

Eloise Jarvis

Eloise Jarvis

Researcher
Beacon Research Operations

Ritu Baral

Managing Director, Health Care – Biotechnology Research Analyst
Cowen
Peter Stein

Peter Stein

Former Director, Office of New Drugs, CDER
FDA
Jason Pitts

Jason Pitts

Principal
General Atlantic
Natalie Sacks

Natalie Sacks

Partner
Novo Holdings US
Paul Matteis

Paul Matteis

Managing Director & Head of Therapeutics Research
Stifel
Chris Weyre

Chris Weyrer

Principal
Vida Ventures

Academic Titans & Clinical Thought Leaders

zoe fasari

Zohreh Farsi

Senior Group Leader/ Research Scientist
Broad Institute
Stephanie Jones

Stephanie R Jones

Professor of Neuroscience
Brown University

Ernest Pedapati

Professor, UC Department of Psychiatry and Behavioral Neuroscience
Cincinnati Children’s Hospital
Craig Erickson

Craig Erickson

Associate Professor
Cincinnati Children’s Hospital
Rouba Kozak

Rouba Kozak

Former Director of Mental Health, Translational Sciences
FNIH

Joseph T. Coyle

Eban S Draper Professor of Psychiatry and Past-Chairman of Psychiatry
Harvard Medical School
Jordan Smoller

Jordan Smoller

Professor of Psychiatry
Harvard Medical School
Scott Thompson

Scott Thompson

Professor, Department of Psychiatry
University of Colorado Anschutz Medical Campus
John Salamone

John Salamone

Board of Trustees Distinguished Professor & Director of Behavioral Neuroscience Professor
University of Connecticut
Marco Pignatelli

Marco Pignatelli

Assistant Professor of Psychiatry
WashU Medicine

CRO Innovators Accelerating CNS Research

Shobi Ahmed

CEO
Sama Therapeutics
John Huxter

John Huxter

Associate Director and Head of Rodent EEG
Transpharmation

Enya Paschen

Head of preclinical neuropharmacology
Ulysses Neuroscience
Screenshot-2025-09-10-095445-768x514-1

Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 35+ expert speakers shaping the future of psychiatric R&D

View Presentations & Speakers
Screenshot-2025-09-10-095245-768x513-1 (1)

Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider in neuropsychiatric and neurodevelopment research

Explore Sponsorship Options
Screenshot-2025-09-10-095258-768x513-1

Join Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and regulatory voices driving real-world adoption

Register Now